PixCell Medical

PixCell Medical
PixCell Medical develops and commercializes point-of-care blood diagnostic solutions for rapid and accurate results.
About
What does PixCell Medical do?
PixCell Medical has created breakthrough diagnostic tools that radically simplify blood testing for physicians and patients globally. Their flagship product, HemoScreen, is a portable, AI-powered hematology analyzer that provides lab-quality complete blood count (CBC) results at the point of care, enabling rapid insights for quick diagnosis and treatment. (formerly Hemoscreen.)
What is PixCell Medical's revenue?
StartupHub estimates PixCell Medical's annual revenue at $13.0M (range $7.3M to $19.2M, 66% confidence), based on comparable companies in the sector.
What is PixCell Medical's valuation?
StartupHub estimates PixCell Medical's effective valuation at $7.8M (range $5.0M to $12.0M, 10% confidence), based on comparable companies in the sector.
How much funding has PixCell Medical raised?
PixCell Medical has raised a total of $2M in funding. The most recent round on record is Strategic.
Where is PixCell Medical headquartered?
PixCell Medical is headquartered in Yokneam Illit, Israel.
When was PixCell Medical founded?
PixCell Medical was founded in 2007.
What industry does PixCell Medical operate in?
PixCell Medical operates in Healthcare, Point of care, Blood, MedTech, HealthTech, Point-of-Care Diagnostics.
How many employees does PixCell Medical have?
PixCell Medical has approximately 74 people on record.
“PixCell Medical erhielt eine Förderung in Höhe von 2,5 Millionen Euro von der Europäischen Kommission, um die Kommerzialisierung ihrer disruptiven Bluttest-Technologie zu unterstützen.”
View on Reddit“PixCell Medical obtient une subvention de 2,5 millions EUR de la Commission européenne pour soutenir la commercialisation de sa technologie révolutionnaire d'analyse sanguine.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.